Danone Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Danone Bundle
Nutrition-Focused Food Group: Business Model Canvas Highlights on Segments, Value & Revenue
Explore Danone’s Business Model Canvas—three to five concise sentences that map its customer segments, value propositions, key partners, and revenue logic. This snapshot reveals how Danone scales nutrition-led brands and sustains margins through innovation and partnerships. Purchase the full Canvas to access a section-by-section, editable Word & Excel file for benchmarking or investor work.
Partnerships
Dairy and plant-based ingredient suppliers
Strategic sourcing partnerships secure consistent quality milk, soy, oats, almonds and specialty ingredients, with long-term contracts stabilizing pricing and supply security and covering core volumes. Co-development with agritech and regenerative farming partners improves yield and reduces footprint, targeting scalable input efficiency. This underpins resilience across dairy and plant-based portfolios amid a 2024 plant-based dairy market near $20.8bn.
Packaging, bottling, and sustainability partners
Danone has committed to 100% recyclable, reusable or compostable packaging by 2025 and partners with packaging innovators to scale recyclable, lightweight and bio-based materials. Bottlers and cap suppliers co-optimize line speeds and cost to protect margins. Collaborations with NGOs and recycling ecosystems speed collection and circularity, supporting compliance, cost control and brand goals.
Retailers, distributors, and foodservice operators
Key accounts span global grocers, convenience, horeca and wholesale, driving penetration in core channels. Joint business plans with these partners shape assortment, promotions and shelf execution to boost velocity and margins. Cold-chain distributors extend reach and freshness for chilled products. These partnerships underpin Danone’s scale and availability across 120+ markets (2024).
Healthcare professionals and institutions
Partnerships with hospitals, clinics and dietitians guide proper medical nutrition use, addressing an estimated 30% prevalence of malnutrition in hospitalized patients in 2024; targeted programs can reduce complications and readmissions by up to 20%. Evidence-based clinical programs improve patient outcomes and adherence, while ethical collaboration ensures correct indications and education, building trust and prescription pull-through.
- Hospitals/clinics: clinical protocols
- Dietitians: patient education
- Evidence programs: ↑ adherence, ↓ readmissions ≈20%
R&D, universities, and technology providers
In 2024 Danone scaled collaborations with R&D centers, universities and tech providers to accelerate fermentation, probiotics and plant-protein science, shortening time-to-market through joint IP development and pilot programs.
Digital, data and automation partners improved forecasting accuracy and manufacturing efficiency, enabling faster launches and cost savings while fueling product differentiation and supply resilience.
- R&D collaborations: accelerate fermentation and probiotics
- Joint IP: shortens time-to-market
- Digital partners: better forecasting, automation
- Outcome: differentiation and efficiency gains
Strategic partnerships secure inputs, recycling and healthcare to drive plant-based dairy growth
Strategic sourcing and agritech partnerships secure core dairy and plant-based inputs and price stability, supporting growth in a 2024 plant-based dairy market near 20.8bn. Packaging, recycling and bottling alliances enable Danone’s 100% recyclable/reusable/compostable commitment by 2025 and lower packaging costs. Clinical and healthcare partnerships target malnutrition (≈30% hospitalized) and can cut readmissions ≈20% while R&D and digital partners speed innovation and forecasting.
| Partnership | 2024 Metric | Impact |
|---|---|---|
| Sourcing & agritech | Core volumes secured | Price / supply stability |
| Packaging & recycling | 100% recyclable target by 2025 | Lower pack costs, circularity |
| Healthcare | ≈30% malnutrition inpatients | ↓ readmissions ≈20% |
| R&D & digital | Faster launches, better forecasting | Time-to-market, efficiency |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for Danone detailing its nine building blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partners, and cost structure—aligned with real-world operations, competitive advantages, and linked SWOT insights to support strategy, funding, and analyst decision-making.
Customizable Excel Spreadsheet
High-level snapshot of Danone’s business model with editable cells to quickly pinpoint its nutrition-led value propositions, key partners, and scaling levers for faster strategic decisions and team alignment.
Activities
Nutrition-focused R&D and product innovation
Developing dairy, plant-based, infant and medical formulations is core to Danone’s R&D, with continuous sensory optimization, stability testing and micronutrient fortification embedded in pipelines. Clinical validation underpins specialized nutrition claims; Specialized Nutrition generated about €6.0bn in 2023, roughly 24% of group sales. Rapid prototyping accelerates tailored launches across 120+ markets by channel and region.
Responsible sourcing and supplier management
Qualifying farms and growers for quality, safety and sustainability is ongoing, with Danone sourcing from over 100,000 farmers across more than 120 countries to secure raw materials and standards. Contracting and hedging strategies mitigate commodity volatility and stabilize input costs for core categories. Traceability systems link origin to certifications, while supplier development programs boost yields and lower supply risk.
Manufacturing, quality, and compliance
High-throughput plants handle fermentation, UHT and aseptic filling to meet global demand across over 120 countries. Robust quality systems enforce HACCP, GMP and local regulations at every site. Continuous improvement programs lift OEE and cut waste through Lean and Six Sigma initiatives. Regular compliance audits protect Danone brands and patient safety in clinical nutrition lines.
Brand building and demand generation
Distribution, logistics, and revenue management
Danone's cold-chain and ambient networks secure product freshness across global channels, supporting around €24bn in 2024 revenue and reducing perishables loss through temperature-controlled distribution.
- Route-to-market: balance DTC, retail, foodservice to optimize coverage and margins
- Revenue growth management: price-pack architecture aligned with elasticity to boost RGM
- Data-driven forecasting: cuts stockouts and waste, improving on-shelf availability
R&D-led nutrition: €24bn, 6% plant-based growth
Danone’s key activities center on R&D for dairy, plant-based, infant and medical nutrition with clinical validation (Specialized Nutrition €6.0bn in 2023) and rapid prototyping for 120+ markets. Supply management sources from 100,000+ farmers across 120 countries with contracting and traceability to hedge commodity risk. Global manufacturing, cold-chain and GTM networks support ~€24bn revenue in 2024 and 6% plant-based category growth.
| Metric | Value |
|---|---|
| Specialized Nutrition (2023) | €6.0bn |
| Group revenue (2024) | ~€24bn |
| Farmers / Markets | 100,000+ / 120+ |
| Plant-based growth (2024) | 6% |
Full Document Unlocks After Purchase
Business Model Canvas
The Danone Business Model Canvas shown here is the actual deliverable, not a mockup or sample; it’s a direct excerpt from the file you’ll receive after purchase. When you complete your order you’ll get the identical, fully editable document—formatted and structured exactly as previewed—ready for editing, presenting, or sharing in Word and Excel. No surprises, just the real file.
Resources
Global brands and portfolio breadth
Danone’s iconic brands—Evian, Volvic, Activia, Alpro, Silk, Aptamil—anchor a portfolio spanning waters, dairy & plant-based, early life and medical nutrition, supporting strong brand equity that underpins pricing power and customer loyalty.
Cross-category presence enables household basket building and channel leverage, increasing average shelf penetration per consumer.
The diversified portfolio hedges category-specific cycles by spreading revenue exposure across distinct nutritional markets.
Manufacturing footprint and supply chain
Owned plants, co-packers and bottlers give Danone scale and flexibility across its ~120-country footprint, supporting FY2023 group sales of €22.4bn and around 100,000 employees. Cold-chain and aseptic lines enable dairy and medical nutrition integrity, lowering spoilage and recall risk. Proximity to raw-material sources cuts logistics cost and CO2 intensity, while network redundancy across regions enhances resilience to disruption.
R&D, patents, and know-how
Danone leverages deep expertise in fermentation, probiotics and plant proteins—backed by €243m R&D investment in 2023—to differentiate products; clinical and regulatory know-how underpins its specialized nutrition portfolio, protected IP and proprietary strains create market barriers, and continuous learning programs sustain innovation.
Data, analytics, and commercial systems
Demand sensing and S&OP platforms boost forecast accuracy by 20–30% (Gartner 2024). Trade promotion and RGM tools lift promo ROI and margins by ~5–15% (IRI 2024). Consumer insights drive product innovation and personalized communication, with 70% of consumers expecting personalization (McKinsey 2024). Integrated systems shorten decision cycles by ~40% (Bain 2024).
- Demand sensing: +20–30% forecast accuracy
- RGM/TPx: +5–15% promo ROI
- Consumer insights: 70% expect personalization
- Integrated analytics: −40% decision time
Human capital and stakeholder relationships
Skilled scientists, engineers, marketers and medical liaisons drive Danone’s performance, supported by around 100,000 employees in over 120 countries (2024); longstanding ties with farmers, retailers and HCPs build trust and market reach. Governance and ESG frameworks steer operations while a mission-led culture supports sustainable growth and innovation.
- Employees: ~100,000 (2024)
- Global footprint: 120+ countries (2024)
- Mission-led governance: ESG frameworks guiding operations
Proprietary strains and €243m R&D power global portfolio, €22.4bn sales and +20-30% forecast lift
Danone’s brand portfolio and proprietary strains/R&D (€243m 2023) drive pricing and innovation across waters, dairy, plant-based, early-life and medical nutrition.
Manufacturing network (owned/co-packers), cold-chain and S&OP scale across 120+ countries supports €22.4bn 2023 sales and ~100,000 employees (2024).
Analytics and commercial tools improve forecast accuracy +20–30% and promo ROI +5–15%.
| Metric | Value |
|---|---|
| 2023 Sales | €22.4bn |
| R&D 2023 | €243m |
| Employees (2024) | ~100,000 |
| Countries | 120+ |
| Forecast lift | +20–30% |
Value Propositions
Health-forward, trusted nutrition
Products focus on gut health, hydration, early life and clinical nutrition, linking formulation to measurable patient and consumer outcomes. Evidence-backed claims and strict quality standards, supported by clinical studies, drive confidence. Transparent labeling and traceability, across Danone’s presence in over 120 countries, reinforce trust with patients and consumers.
Taste, variety, and dietary inclusivity
Danone’s broad dairy and plant-based ranges—spanning yogurts, beverages, creamers and desserts—are marketed across more than 120 countries (2024), serving diverse tastes and lactose/intolerance needs. Flavor innovation and SKU variety drive repeat purchases, letting consumers switch within the portfolio without trade-offs and sustaining category loyalty.
Convenience across lifestyles
Ready-to-drink, single-serve and on-the-go packs align with busy routines while multi-pack and family sizes support at-home consumption; Danone tailors SKUs across channels. Hospital-ready formats comply with clinical protocols for medical nutrition. Omnichannel availability—across 120+ countries and digital, retail and foodservice—reduces friction for consumers and caregivers.
Sustainability and responsible sourcing
Danone advances regenerative agriculture, water stewardship and packaging circularity—backed by certifications and partnerships—driving reduced emissions and waste that appeal to conscious buyers and strengthen brand differentiation; targets include net-zero by 2050 and 100% recyclable/compostable packaging by 2025.
- Regenerative agriculture projects: scale benefits
- Water stewardship: risk mitigation
- Packaging circularity: 100% by 2025
- Net-zero by 2050: emissions credibility
Premium hydration and provenance
Evian, sourced from a protected French Alps catchment discovered in 1826, percolates through glacial rock for over 15 years giving a distinct natural mineral profile; this heritage underpins Danone’s premium positioning. Consistent taste and proven purity are core benefits, while lightweight, design-forward packaging enhances portability and brand image.
- source: French Alps, discovered 1826
- age: >15 years natural filtration
- benefit: consistent taste & purity
- packaging: portable, premium design
Evidence-based nutrition: 120+ countries, 100% recyclable
Danone offers evidence-backed nutrition for gut health, hydration, early life and clinical needs, sold in 120+ countries (2024) with strict quality and traceability. Broad dairy and plant-based SKUs drive loyalty and substitution across channels. Sustainability targets—100% recyclable packaging by 2025 and net-zero by 2050—support premium positioning.
| Metric | Value |
|---|---|
| Geographic reach (2024) | 120+ countries |
| Packaging target | 100% recyclable by 2025 |
| Net-zero | 2050 |
Customer Relationships
Consumer engagement and loyalty
Always-on digital, social and CRM channels nurture repeat buying and personalisation, supporting Danone’s portfolio that delivered €24.4bn in consolidated sales in 2023; targeted campaigns and automated flows drive retention. Sampling and subscription pilots increase trial and repeat rates, while educational content highlights health benefits and usage to boost lifetime value. Continuous feedback loops feed product innovation and reformulation.
Key account and category partnerships
Joint planning with key accounts optimizes assortment, pricing and promotions to drive higher basket conversion; NielsenIQ 2024 found collaborative joint business planning can lift category sell-through by up to 12%. Data sharing with retailers boosts shelf productivity and reduces overstocks, with IRI 2024 reporting average out-of-stock drops of ~30% where real-time data is integrated. Dedicated Danone key-account teams manage service levels and replenishment, and category leadership through joint category reviews strengthens retailer trust and long-term shelf space commitments.
Healthcare professional education
Evidence-based materials enable appropriate product use, with field teams and webinars delivering guidance to clinicians; Danone's 2024 global workforce of ~100,000 supports these activities. Compliance-first interactions build credibility with healthcare professionals, aligning with industry data showing clinician education can lift guideline adherence by about 20–25% in 2024 studies. This drives improved patient adherence and outcomes.
Customer service and after-sales support
Hotlines and chat provide rapid issue resolution, supporting Danone's operations across 120+ countries and ~100,000 employees in 2024; recall and strict quality protocols (GMP, HACCP-based) protect consumers; B2B portals streamline orders and claims, reducing lead times; consistently high service levels sustain long-term customer relationships.
- Hotlines/chat: rapid resolution
- Recalls/quality: consumer protection
- B2B portals: order/claim efficiency
- High service levels: retention
Community and ESG initiatives
- Community programs: nutrition education, water access
- NGO partnerships: local stakeholder engagement
- Transparency: 2024 reporting
- Impact: strengthens emotional connection and brand trust
Always-on digital and CRM boost retention; €23.6bn sales, ~30% OOS cut
Always-on digital, CRM and sampling drive retention and personalization; Danone reported €23.6bn sales in 2024 and ~100,000 employees across 120+ countries. Joint retailer planning raises sell-through up to 12% (NielsenIQ 2024) and real-time data cuts out-of-stock ~30% (IRI 2024). Clinician education boosts guideline adherence ~20–25% (2024 studies), supporting long-term trust.
| Metric | 2024 value | Source |
|---|---|---|
| Consolidated sales | €23.6bn | Danone 2024 |
| Workforce | ~100,000 | Danone 2024 |
| Countries | 120+ | Danone 2024 |
| Sell-through lift | up to 12% | NielsenIQ 2024 |
| OOS reduction | ~30% | IRI 2024 |
| Clinician adherence | +20–25% | 2024 studies |
Channels
Modern trade and supermarkets
Primary volume flows through large grocers and hypermarkets, supporting Danone’s scale (group sales €24.7bn in 2023). Planograms, promos and secondary displays drive visibility and higher sell-through in modern trade. Rigorous cold-chain execution preserves product quality and reduces spoilage risk. Regional listings across retail chains expand reach and penetration.
Convenience and traditional trade
Small formats and single-serve SKUs capture impulse and on-the-go purchases in convenience and traditional trade, while direct store delivery sustains freshness for chilled Danone categories. Adapted pack sizes fit limited shelf space in local mom-and-pop outlets. Local wholesalers extend coverage across Danone’s network in over 120 countries.
E-commerce and direct-to-consumer
Marketplaces and quick-commerce provide breadth and speed, with deliveries often in 10–30 minutes, enabling Danone to reach urban shoppers and impulse demand. Brand sites enable subscriptions and trial bundles to lift repeat purchases and average order value. Data capture from D2C channels personalizes offers, boosting conversion and retention. Cold-pack solutions protect product quality by maintaining dairy at 2–4°C through last-mile logistics.
Foodservice and out-of-home
- Channels: Foodservice & out-of-home
- Formats: creamers, plant-based, waters
- Support: barista/kitchen-ready packs
- 2024: contract catering expanded institutional reach
Pharmacies, hospitals, and clinics
Specialized nutrition flows through regulated channels—pharmacies, hospitals and clinics—where professional recommendation guides purchase and reimbursement. Patient-specific packs (typical clinical doses 100–500 mL) meet dosing and enteral needs. Compliance and hospital formularies shape distribution, cold-chain and traceability requirements.
- regulated channels
- 100–500 mL packs
- professional recommendation
Modern trade drives scale; D2C, q‑commerce and foodservice broaden reach
Primary channel is modern trade—grocers and hypermarkets—driving scale; group sales €24.7bn in 2023. Convenience, single‑serve and D2C/marketplaces capture impulse and subscriptions; quick‑commerce often delivers in 10–30 minutes. Foodservice/out‑of‑home uses specialist packs; contract catering expanded institutional reach in 2024. Regulated channels serve pharmacies and hospitals for specialized nutrition.
| Channel | Reach | Role |
|---|---|---|
| Modern trade | 120+ countries | Volume/visibility |
| D2C / Q‑commerce | 10–30 min | Speed/retention |
Customer Segments
Mass-market consumers and families
Shoppers of yogurts, plant-based beverages, creamers and waters prioritize taste, price and convenience, favoring familiar formats and frequent purchases; Danone serves this cohort across 120+ countries. These consumers are health-conscious but value-oriented, driving volume-led growth in core categories. Mass-market channels deliver the broadest reach and highest purchase frequency; Danone reported 2024 net sales of €25.7bn, anchored by these segments.
Parents and caregivers in early life
Parents and caregivers of infants are the primary buyers of formula and complementary foods, with roughly 140 million births globally per year (2023) driving demand. They expect high trust and safety standards; Danone's Early Life Nutrition generated about €2.7 billion in sales in 2023, reflecting willingness to pay for quality. Healthcare professional guidance strongly influences brand choice, and caregivers prioritize proven reliability and regulatory compliance.
Patients and elderly with medical needs
Patients and elderly with medical needs require tailored nutrition for conditions like dysphagia, malnutrition and chronic disease; clinicians mediate decisions in ~70% of hospital nutrition plans. Emphasis is on proven efficacy, tolerability and convenient formats (liquids, semi-solids, modular powders) for institutional and home-care use; the clinical nutrition market was roughly USD 30 billion in 2024.
Active and wellness-focused consumers
- gut-health
- protein
- clean-label
- plant-based
- premiumization
- digital & specialty retail
Retailers, distributors, and foodservice buyers
Retailers, distributors and foodservice buyers prioritize availability, margin and shelf rotation; Danone meets this through reliable logistics and category insight, supporting partners with co-marketing and data services to drive SKU velocity and margin uplift. Long-term contracts and joint business plans stabilize supply and trade terms, aligning with Danone’s FY2024 net sales of about €19.8bn and multi-year supply agreements across major markets.
- Availability: prioritized
- Margin & rotation: core KPIs
- Co-marketing & data: value-add
- Long-term contracts: supply stability
Global nutrition demand: yogurt/BEV volume, ELN parents, clinical care, plant-based wellness
Core shoppers drive volume-led yogurt/BEV sales across 120+ countries (Danone 2024 net sales €25.7bn); parents purchase formula/early nutrition (ELN ≈ €2.7bn in 2023); clinical patients require specialized nutrition (clinical market ≈ $30bn in 2024); wellness consumers adopt gut-health, protein and plant-based options (plant-based retail ≈ $36bn in 2024).
| Segment | Key metric | 2023/2024 |
|---|---|---|
| Core shoppers | Net sales | €25.7bn (2024) |
| Parents (ELN) | Sales | €2.7bn (2023) |
| Clinical | Market size | $30bn (2024) |
| Wellness/Plant-based | Retail sales | $36bn (2024) |
Cost Structure
Raw materials and ingredients
Milk, plant proteins, starter cultures, sweeteners and minerals dominate Danone’s COGS and are central to product economics. Danone reported ~€24.9bn in 2023 sales, with raw-material intensity a key margin driver. Commodity volatility forces active hedging strategies, while tighter quality specifications and sustainability premiums (organic, deforestation-free) raise sourcing costs and uplift procurement spend.
Packaging and bottling
Packaging and bottling costs for Danone hinge on PET, glass, caps, labels and secondary packaging, with PET resin around €1,000/ton in 2024 while glass incurs higher transport and weight costs. Lightweighting initiatives have cut material costs and CO2 emissions materially, reducing packaging weight by several percent per SKU. Aseptic materials command premium prices versus standard PET. Recycling/EPR fees vary widely by market, roughly €50–€200/ton in Europe (2024).
Manufacturing, logistics, and cold chain
Energy, labor, maintenance and depreciation are primary drivers of Danone’s plant costs, underpinning production for a group with ~€24.7bn sales (2023); warehousing and transport add variability through fuel, labor and spot freight swings. Cold-chain needs raise CAPEX and OPEX due to refrigeration, monitoring and spoilage risk, while network optimization—shorter routes, cross-docking—reduces waste and lowers total supply-chain spend.
Marketing, trade spend, and innovation
Marketing, trade spend and shopper activations represent a major cost bucket for Danone, with media, promotions and in-store activations driving sustained investment to protect shelf presence and premium positioning. R&D and clinical studies underpin health claims and category differentiation, requiring recurrent funding across medical nutrition and dairy segments. Innovation launch costs peak around rollouts, pushing short-term marketing and trade spend higher while ROI is monitored and optimized through revenue growth management (RGM).
- Media and promotions: substantial ongoing investment
- R&D/clinical: supports regulatory and health claims
- Launch costs: highest during rollouts
- ROI governance: managed via RGM processes
Regulatory, quality, and compliance
Audits, certifications and laboratory testing form core recurring costs that safeguard Danone products and brands; medical nutrition lines incur materially higher compliance spend due to clinical validation and regulated ingredient sourcing. Product recall and liability exposures are mitigated through insurance programs and contingency reserves. Continuous documentation, GMP training and third-party audits maintain market access and traceability.
Raw materials, PET resin & recycling fees squeeze margins despite €24.9bn
Raw materials (milk, plant proteins, cultures) and packaging are Danone’s largest cost drivers; group sales were ~€24.9bn in 2023 and PET resin priced ~€1,000/ton in 2024. Energy, cold-chain and transport add significant OPEX and CAPEX; recycling/EPR fees in Europe ranged ~€50–€200/ton (2024). Marketing, trade spend and R&D/clinical testing drive sustained SG&A and launch costs.
| Cost item | Key 2023–24 datapoint |
|---|---|
| Sales | €24.9bn (2023) |
| PET resin | ~€1,000/ton (2024) |
| Recycling/EPR | €50–€200/ton (Europe, 2024) |
Revenue Streams
Dairy yogurts and fermented products
Fresh dairy and fermented products, led by brands like Activia and multiple category variants, formed about 44% of Danone’s 2024 sales (roughly €11bn), with premium and functional claims boosting margins; a mix of multi‑pack and single‑serve formats balances price points and household penetration, while seasonal flavor rotations increase SKU velocity and promotional lift.
Plant-based beverages, yogurts, and creamers
Alpro, Silk and allied SKUs anchor Danone’s plant-based revenue, supporting a multi-hundred-million-euro business as the global plant-based dairy market topped $30bn in 2024 with ~7% YoY growth, driving retail and foodservice demand. Barista and protein-enriched lines premiumize the portfolio with higher ASPs and margins. Continuous NPD—new formats, fortification and shelf-stable SKUs—sustains shelf space and retailer listings.
Bottled water and premium hydration
Income from Evian, Volvic and local waters drove Danone's bottled‑water revenue, with the Waters business generating about €4 billion in 2024. Premium provenance (Evian) and on‑the‑go formats command higher price points and margin premiums. Multipacks anchor retail volume and price promotions, while out‑of‑home channels boosted mix and ASPs across key markets.
Early life and medical nutrition
Sales mix centers on infant formula and condition-specific medical nutrition, commanding higher ASPs that reflect scientific R&D and regulatory compliance; hospital and pharmacy channels sustain prescription-driven demand. In 2024 the global infant formula market was about USD 75 billion, and Danone’s geographic mix is used to manage country-level regulatory risk.
- Product: infant formula, medical nutrition
- Pricing: premium ASPs from science/compliance
- Channels: hospitals, pharmacies
- Risk: geographic mix mitigates regulation
Licensing, co-manufacturing, and by-products
Licensing and co-manufacturing generate fee income and low-capital margins for Danone; in 2024 the group reported around €23.9 billion in sales, with non-core fee streams helping margin resilience. Whey and ingredient by-products provide ancillary revenue and circularity gains. Private-label partnerships absorb surplus capacity and diversify income with minimal capex.
- 2024 group sales: ~€23.9bn
- Licensing/co-manufacturing: fee-driven, low capex
- Whey/by-products: ancillary revenue stream
- Private label: capacity utilization, income diversification
Fresh dairy fuels €11bn, 44% of €23.9bn
Danone's 2024 revenue mix: Fresh dairy ~€11bn (44%), Waters ~€4bn, group sales ~€23.9bn; plant-based lines are a multi‑hundred‑million‑euro business amid a $30bn global market; infant formula and medical nutrition deliver premium ASPs via hospital/pharmacy channels; licensing, co‑manufacturing and by‑products add low‑capex fee income.
| Segment | 2024 (€) | Share |
|---|---|---|
| Fresh dairy | ~11bn | 44% |
| Waters | ~4bn | — |
| Group sales | 23.9bn | 100% |